Psychiatry
[Psychiatry archives]

1. Aretouli E, Tsilidis KK, Brandt J. Four-year outcome of mild cognitive impairment: The contribution of executive dysfunction. Neuropsychology. 2013 Jan;27(1):95-106.
Key words: mild cognitive impairment, executive dysfunction
http://www.ncbi.nlm.nih.gov/pubmed/23106114

2. Crum RM, La Flair L, Storr CL, Green KM, Stuart EA, Alvanzo AA, Lazareck S, Bolton JM, Robinson J, Sareen J, Mojtabai R. Reports of drinking to self-medicate anxiety symptoms: longitudinal assessment for subgroups of individuals with alcohol dependence. Depress Anxiety. 2013 Feb;30(2):174-83.
Key words: addiction, alcoholism, alcohol use disorder, anxiety disorder, epidemiology, generalized anxiety disorder, panic disorder, phobia
http://www.ncbi.nlm.nih.gov/pubmed/23280888

3. Dailey MJ, Moran TH. Glucagon-like peptide 1 and appetite. Trends Endocrinol Metab. 2013 Feb;24(2):85-91.
Key words: GLP-1, appetite, gastrointestinal motility, food intake
http://www.ncbi.nlm.nih.gov/pubmed/23332584

4. Dunn KE, Defulio A, Everly JJ, Donlin WD, Aklin WM, Nuzzo PA, Leoutsakos JM, Umbricht A, Fingerhood M, Bigelow GE, Silverman K. Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users. Exp Clin Psychopharmacol. 2013 Feb;21(1):74-83. doi: 10.1037/a0030743.
Key words: employment, injection drug use, reinforcement
http://www.ncbi.nlm.nih.gov/pubmed/23205722

5. Goodwin AK, Kaminski BJ, Weerts EM. Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology (Berl). 2013 Feb;225(3):637-46.
Key words: GHB, GBL, 1,4-BD, primates
http://www.ncbi.nlm.nih.gov/pubmed/22945514

6. Jones HE, Chisolm MS, Jansson LM, Terplan M. Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research. Addiction. 2013 Feb;108(2):233-47.
Key words: Naltrexone, opioids, pregnancy
http://www.ncbi.nlm.nih.gov/pubmed/22471668

7. Liang NC, Bello NT, Moran TH. Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations. Int J Obes (Lond). 2013 Feb;37(2):272-8.
Key words: combinational therapy, naltrexone, exendin-4, GLP-1, opioids, conditioned taste aversion
http://www.ncbi.nlm.nih.gov/pubmed/22310470

8. Miller L, Riddle MA, Pruitt D, Zachik A, Dosreis S. Antipsychotic treatment patterns and aggressive behavior among adolescents in residential facilities. J Behav Health Serv Res. 2013 Jan;40(1):97-110.
Key words: adolescents, psychosis, residential facilities
http://www.ncbi.nlm.nih.gov/pubmed/23319375

9. Papazoglou A, Jacobson LA, Zabel TA. More than intelligence: distinct cognitive/behavioral clusters linked to adaptive dysfunction in children. J Int Neuropsychol Soc. 2013 Feb;19(2):189-97.
Key words: activities of daily living, executive function, intellectual disability, cluster analysis, mood, behavioral symptoms
http://www.ncbi.nlm.nih.gov/pubmed/23298775

10. Weerts EM, McCaul ME, Kuwabara H, Yang X, Xu X, Dannals RF, Frost JJ, Wong DF, Wand GS. Influence of OPRM1 Asn40Asp variant (A118G) on [11C]carfentanil binding potential: preliminary findings in human subjects. Int J Neuropsychopharmacol. 2013 Feb;16(1):47-53.
Key words: alcohol use disorders, genetics, imaging, ? opioid receptors, naltrexone
http://www.ncbi.nlm.nih.gov/pubmed/22397905

Return to top of Publications - Psychiatry